Summary

● On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

● From a short-term investment perspective, the company presents a deteriorated fundamental situation


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● The company has insufficient levels of profitability.

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Over the past twelve months, analysts' opinions have been revised negatively.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.